GEDEA BIOTECH
PrivateLast Round
Grant
Feb 29, 2024
Total Funding Raised
$3.74M
Momentum Score
50 /100
Company Overview
GEDEA BIOTECH is a biotechnology company that develops pHyph, an antibiotic-free treatment for vaginal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GEDEA BIOTECH Comps
Public and private peers based on sector, stage, and business model.
GEDEA BIOTECH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 29, 2024 | ||||
| VC Round | Nov 15, 2023 | ||||
| VC Round | Jun 5, 2023 | ||||
| Grant | Apr 4, 2023 | ||||
| Grant | Dec 11, 2019 | ||||
Grant | May 24, 2018 |
Key People
Founding team and executive leadership
GEDEA BIOTECH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Almi Invest AB | VC Round |
| Vinnova | Grant |
| Swelife | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 182% MoM, reaching 1.3K.
- Jan 27, 2026
Julie Waras Brogren appointed as new CEO.
GEDEA BIOTECH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GEDEA BIOTECH's valuation, stock price, and market status.
